Trial intelligence / Profile preview

TAP block versus caudal block for postoperative analgesia in children undergoing unilateral inguinal hernia repair

ACTRN12612001074886Phase 2Completed

Sponsor
Yusheng Pharmaceutical
Start
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of levobupivacaine and sevoflurane in postoperative pain (2 arms), sponsored by Yusheng Pharmaceutical. Primary endpoints: Time to first rescue medication and Number of patients not requiring rescue analgesia. Started Oct 2012; status: completed.

02

Drugs

levobupivacainesevoflurane
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ACTRN12612001074886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612001074886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call